Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Yannick D MullerNseir GhalebSamuel RotmanJulien VionnetMatthieu HalfonEmmanuelle CatanaDéla GolshayanJean-Pierre VenetzVincent AubertManuel PascualPublished in: Transplant international : official journal of the European Society for Organ Transplantation (2018)